Skip to content

Annexon ANNX Earnings yield

Earnings yield at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.4%-1.1pp
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
-8.1%+1.2pp
Omeros logo
OmerosOMER
-43.4%-8.9pp
Vor Biopharma logo
Vor BiopharmaVOR
-733.6%-1,389pp
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-25.7%-6.8pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-7.7%-3.7pp

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$868.37M+223%
Enterprise value$718.59M+261%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Calculated from Annexon’s reported figures.

Based on trailing twelve months.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's earnings yield?
Annexon (ANNX) reported earnings yield of -23.8% in Q1 2026.
How has Annexon's earnings yield changed year-over-year?
Annexon's earnings yield increased by 69.9% year-over-year, from -79% to -23.8%.
What is the long-term trend for Annexon's earnings yield?
Over 5 years (2020 to 2025), Annexon's earnings yield has grown at a 33.1% compound annual growth rate (CAGR), from -6.6% to -27.6%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.